Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
CD20
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
15
30
45
60
75
90
105
120
135
150
Rituxan
(rituximab) / Roche
Ocrevus
(ocrelizumab) / Roche
Arzerra
(ofatumumab) / Novartis, Genmab
PF-5230895
/ Emergent Biosolutions, Pfizer
Rixathon
(rituximab biosimilar) / Kyowa Kirin, Sandoz
MK-8808
(rituximab biosimilar) / Merck (MSD)
Ruxience
(rituximab-pvvr) / Pfizer
TRU-015
/ Pfizer
Veltucyn
(veltuzumab) / Gilead
